Two regulators of NF-κB that have been implicated as tumor suppressor genes, DAPK and IRF-1, have been found to be deregulated and present in many samples obtained from patients with acute myelogenous leukemia (AML) [15]. This evidence concerns the gene IRF1 and acute myeloid leukemia.